Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

BioScience Health Innovations (BHIC) Profit After Tax (2020 - 2026)

BioScience Health Innovations has reported Profit After Tax over the past 7 years, most recently at -$229907.0 for Q1 2026.

  • Quarterly Profit After Tax fell 153.87% to -$229907.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$14615.0 through Mar 2026, down 102.58% year-over-year, with the annual reading at $642090.0 for FY2025, 638.03% up from the prior year.
  • Profit After Tax was -$229907.0 for Q1 2026 at BioScience Health Innovations, up from -$233630.0 in the prior quarter.
  • Over five years, Profit After Tax peaked at $457704.0 in Q2 2025 and troughed at -$233630.0 in Q4 2025.
  • The 5-year median for Profit After Tax is -$28917.0 (2022), against an average of $8802.8.
  • The largest YoY upside for Profit After Tax was 899.53% in 2025 against a maximum downside of 2446.39% in 2025.
  • A 5-year view of Profit After Tax shows it stood at -$28917.0 in 2022, then crashed by 32.71% to -$38376.0 in 2023, then skyrocketed by 125.95% to $9957.0 in 2024, then plummeted by 2446.39% to -$233630.0 in 2025, then increased by 1.59% to -$229907.0 in 2026.
  • Per Business Quant, the three most recent readings for BHIC's Profit After Tax are -$229907.0 (Q1 2026), -$233630.0 (Q4 2025), and -$8782.0 (Q3 2025).